Ashland Inc. ( ASH ) Q4 2025 Earnings Call November 5, 2025 10:00 AM EST Company Participants Sandy Klugman Guillermo Novo - Chairman & CEO William Whitaker - Senior VP, CFO & Director of Investor Relations Alessandra Assis - Senior VP and GM of Life Sciences & Intermediates James Minicucci - Senior VP & GM of Personal Care Dago Caceres - SVP & General Manager of Specialty Additives Conference ...
Sales of $478 million, down eight percent from the prior-year quarter Previously announced carboxymethylcellulose (CMC), methylcellulose (MC), Nutraceuticals and Avoca portfolio optimization initiatives (collectively, Portfolio Optimization) reduced overall sales by approximately $38 million or seven percent versus the prior-year quarter. Excluding these initiatives, sales declined one percent ...
WILMINGTON, Del., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) has changed the start time of its fourth-quarter fiscal 2025 earnings webcast being held on Wednesday, November 5, 2025. The event will now begin at 10:00 a.m. ET instead of 9:00 a.m. ET. Attendees that have previously registered do not need to register again.
WILMINGTON, Del., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter fiscal 2025 earnings release at approximately 5 p.m.
WILMINGTON, Del., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced Sandy Klugman joins Ashland as director, Investor Relations (IR), effective October 13, 2025. He will report to William Whitaker, senior vice president and chief financial officer.
WILMINGTON, Del., Aug. 08, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock. The dividend will be payable on September 15, 2025, to stockholders of record at the close of business on September 1, 2025.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.